A detailed history of Vanguard Group Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,242,949 shares of APLT stock, worth $4.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,242,949
Previous 5,322,460 1.49%
Holding current value
$4.61 Million
Previous $24.9 Million 79.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.35 - $8.5 $345,872 - $675,843
-79,511 Reduced 1.49%
5,242,949 $44.6 Million
Q2 2024

Aug 13, 2024

BUY
$4.04 - $6.37 $9.34 Million - $14.7 Million
2,312,170 Added 76.81%
5,322,460 $24.9 Million
Q1 2024

May 10, 2024

SELL
$2.25 - $7.4 $495,429 - $1.63 Million
-220,191 Reduced 6.82%
3,010,290 $20.5 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $3.32 Million - $6.04 Million
1,801,827 Added 126.12%
3,230,481 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $543,881 - $1.2 Million
431,652 Added 43.29%
1,428,654 $3.56 Million
Q2 2023

Aug 14, 2023

BUY
$0.77 - $1.8 $109,222 - $255,324
141,847 Added 16.59%
997,002 $1.28 Million
Q1 2023

May 15, 2023

BUY
$0.75 - $1.21 $43,944 - $70,897
58,593 Added 7.36%
855,155 $692,000
Q4 2022

Feb 10, 2023

BUY
$0.54 - $1.12 $185,381 - $384,494
343,299 Added 75.74%
796,562 $605,000
Q3 2022

Nov 14, 2022

SELL
$0.86 - $1.55 $52,422 - $94,481
-60,956 Reduced 11.85%
453,263 $422,000
Q2 2022

Aug 12, 2022

SELL
$0.76 - $2.64 $73,452 - $255,150
-96,648 Reduced 15.82%
514,219 $488,000
Q1 2022

May 13, 2022

SELL
$1.48 - $6.22 $355,601 - $1.49 Million
-240,271 Reduced 28.23%
610,867 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $7,358 - $15,345
839 Added 0.1%
851,138 $7.62 Million
Q3 2021

Nov 12, 2021

BUY
$13.54 - $22.06 $73,346 - $119,499
5,417 Added 0.64%
850,299 $14.1 Million
Q2 2021

Aug 13, 2021

BUY
$14.05 - $25.04 $11.9 Million - $21.2 Million
844,882 New
844,882 $17.6 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.